NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.27
+0.15 (0.75%)
Nov 22, 2024, 11:03 AM EST - Market open
NAMS Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for NAMS stock have an average target of 33.8, with a low estimate of 30 and a high estimate of 37. The average target predicts an increase of 66.75% from the current stock price of 20.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +77.60% | Nov 21, 2024 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +77.60% | Nov 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +77.60% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +82.54% | Sep 23, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +52.94% | Sep 5, 2024 |
Financial Forecast
Revenue This Year
13.05M
from 14.09M
Decreased by -7.40%
Revenue Next Year
6.49M
from 13.05M
Decreased by -50.25%
EPS This Year
-2.35
from -2.15
EPS Next Year
-1.92
from -2.35
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 40.6M | 38.5M | 61.2M | ||
| Avg | 13.0M | 6.5M | 15.7M | ||
| Low | 3.6M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 188.4% | 195.1% | 842.3% | ||
| Avg | -7.4% | -50.3% | 142.2% | ||
| Low | -74.4% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.22 | -1.68 | -1.27 | ||
| Avg | -2.35 | -1.92 | -1.82 | ||
| Low | -2.46 | -2.24 | -2.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.